Due to the high levels of expression in primary HCC and its induction by multiple TIS inducers, we tested the effect of CC-3 [17], a bispecific CD276-CD3 “T cell engaging” [33] antibody (Fig. 3D). This evidence concerns the gene CD276 and hepatocellular carcinoma.